Literature DB >> 8626998

Successful desensitization for treatment of a fixed drug eruption to allopurinol.

J M Kelso1, R M Keating.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8626998     DOI： 10.1016/s0091-6749(96)70275-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

Review 1.  Fixed drug eruption: a prototypic disorder mediated by effector memory T cells.

Authors:  Yoshiko Mizukawa; Tetsuo Shiohara
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

Review 2.  Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.

Authors:  A G Fam
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.686

3.  Allopurinol desensitization with A 2 weeks modified protocol in an elderly patients with multiple comorbidities: a case report.

Authors:  Adile Berna Dursun; Osman Z Sahin
Journal:  Allergy Asthma Clin Immunol       Date:  2014-10-22       Impact factor: 3.406

4.  The Antioxidant and Xanthine Oxidase Inhibitory Activity of Plumeria rubra Flowers.

Authors:  Siti Sarwani Putri Mohamed Isa; Abdulwali Ablat; Jamaludin Mohamad
Journal:  Molecules       Date:  2018-02-13       Impact factor: 4.411

5.  Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction.

Authors:  Amanda Rocha Firmino Pereira; Marcelo Vivolo Aun; Nathália Coelho Portilho Kelmann; Antônio Abílio Motta; Jorge Kalil; Pedro Giavina-Bianchi
Journal:  Einstein (Sao Paulo)       Date:  2019-11-25

6.  A case of allopurinol-induced fixed drug eruption confirmed with a lymphocyte transformation test.

Authors:  Min-Hye Kim; Eun-Jin Shim; Jae-Woo Jung; Seong-Wook Sohn; Hye-Ryun Kang
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-29       Impact factor: 5.764

Review 7.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.